Copyright Reports & Markets. All rights reserved.

Global Rosuvastatin (CAS 287714-41-4) Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Rosuvastatin (CAS 287714-41-4) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Rosuvastatin (CAS 287714-41-4) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market 2
    • 1.4.1 Global Rosuvastatin (CAS 287714-41-4) Market Size Growth Rate 2
    • 1.4.2 Purity ≥98%
    • 1.4.3 Purity ≥99%
  • 1.5 Market 2
    • 1.5.1 Global Rosuvastatin (CAS 287714-41-4) Market Size Growth Rate 2
    • 1.5.2 5mg Tablet
    • 1.5.3 10mg Tablet
    • 1.5.4 20mg Tablet
    • 1.5.5 40mg Tablet
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Rosuvastatin (CAS 287714-41-4) Market Size, Estimates and Forecasts
    • 2.1.1 Global Rosuvastatin (CAS 287714-41-4) Revenue 2015-2026
    • 2.1.2 Global Rosuvastatin (CAS 287714-41-4) Sales 2015-2026
  • 2.2 Global Rosuvastatin (CAS 287714-41-4), Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Rosuvastatin (CAS 287714-41-4) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Rosuvastatin (CAS 287714-41-4) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Rosuvastatin (CAS 287714-41-4) Competitor Landscape by Players

  • 3.1 Rosuvastatin (CAS 287714-41-4) Sales by Manufacturers
    • 3.1.1 Rosuvastatin (CAS 287714-41-4) Sales by Manufacturers (2015-2020)
    • 3.1.2 Rosuvastatin (CAS 287714-41-4) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Rosuvastatin (CAS 287714-41-4) Revenue by Manufacturers
    • 3.2.1 Rosuvastatin (CAS 287714-41-4) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Rosuvastatin (CAS 287714-41-4) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Rosuvastatin (CAS 287714-41-4) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Rosuvastatin (CAS 287714-41-4) Revenue in 2019
    • 3.2.5 Global Rosuvastatin (CAS 287714-41-4) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Rosuvastatin (CAS 287714-41-4) Price by Manufacturers
  • 3.4 Rosuvastatin (CAS 287714-41-4) Manufacturing Base Distribution, Product Types
    • 3.4.1 Rosuvastatin (CAS 287714-41-4) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Rosuvastatin (CAS 287714-41-4) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Rosuvastatin (CAS 287714-41-4) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size 2 (2015-2026)

  • 4.1 Global Rosuvastatin (CAS 287714-41-4) Market Size 2 (2015-2020)
    • 4.1.1 Global Rosuvastatin (CAS 287714-41-4) Sales 2 (2015-2020)
    • 4.1.2 Global Rosuvastatin (CAS 287714-41-4) Revenue 2 (2015-2020)
    • 4.1.3 Rosuvastatin (CAS 287714-41-4) Average Selling Price (ASP) 2 (2015-2026)
  • 4.2 Global Rosuvastatin (CAS 287714-41-4) Market Size Forecast 2 (2021-2026)
    • 4.2.1 Global Rosuvastatin (CAS 287714-41-4) Sales Forecast 2 (2021-2026)
    • 4.2.2 Global Rosuvastatin (CAS 287714-41-4) Revenue Forecast 2 (2021-2026)
    • 4.2.3 Rosuvastatin (CAS 287714-41-4) Average Selling Price (ASP) Forecast 2 (2021-2026)
  • 4.3 Global Rosuvastatin (CAS 287714-41-4) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size 2 (2015-2026)

  • 5.1 Global Rosuvastatin (CAS 287714-41-4) Market Size 2 (2015-2020)
    • 5.1.1 Global Rosuvastatin (CAS 287714-41-4) Sales 2 (2015-2020)
    • 5.1.2 Global Rosuvastatin (CAS 287714-41-4) Revenue 2 (2015-2020)
    • 5.1.3 Rosuvastatin (CAS 287714-41-4) Price 2 (2015-2020)
  • 5.2 Rosuvastatin (CAS 287714-41-4) Market Size Forecast 2 (2021-2026)
    • 5.2.1 Global Rosuvastatin (CAS 287714-41-4) Sales Forecast 2 (2021-2026)
    • 5.2.2 Global Rosuvastatin (CAS 287714-41-4) Revenue Forecast 2 (2021-2026)
    • 5.2.3 Global Rosuvastatin (CAS 287714-41-4) Price Forecast 2 (2021-2026)

6 North America

  • 6.1 North America Rosuvastatin (CAS 287714-41-4) by Country
    • 6.1.1 North America Rosuvastatin (CAS 287714-41-4) Sales by Country
    • 6.1.2 North America Rosuvastatin (CAS 287714-41-4) Revenue by Country
    • 6.1.3 United States
    • 6.1.4 Canada
    • 6.1.5 Mexico
  • 6.2 North America Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2
  • 6.3 North America Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2

7 Europe

  • 7.1 Europe Rosuvastatin (CAS 287714-41-4) by Country
    • 7.1.1 Europe Rosuvastatin (CAS 287714-41-4) Sales by Country
    • 7.1.2 Europe Rosuvastatin (CAS 287714-41-4) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 UK
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2
  • 7.3 Europe Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2

8 Asia Pacific

  • 8.1 Asia Pacific Rosuvastatin (CAS 287714-41-4) by Region
    • 8.1.1 Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Region
    • 8.1.2 Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Indonesia
    • 8.1.9 Thailand
    • 8.1.10 Malaysia
    • 8.1.11 Philippines
    • 8.1.12 Vietnam
  • 8.2 Asia Pacific Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2
  • 8.3 Asia Pacific Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2

9 Latin America

  • 9.1 Latin America Rosuvastatin (CAS 287714-41-4) by Country
    • 9.1.1 Latin America Rosuvastatin (CAS 287714-41-4) Sales by Country
    • 9.1.2 Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Country
    • 9.1.3 Brazil
  • 9.2 Central & South America Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2
  • 9.3 Central & South America Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2

10 Middle East and Africa

  • 10.1 Middle East and Africa Rosuvastatin (CAS 287714-41-4) by Country
    • 10.1.1 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Country
    • 10.1.2 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 GCC Countries
    • 10.1.5 Egypt
    • 10.1.6 South Africa
  • 10.2 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2
  • 10.3 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Market Facts & Figures 2

11 Company Profiles

  • 11.1 Anuh Pharma LTD
    • 11.1.1 Anuh Pharma LTD Corporation Information
    • 11.1.2 Anuh Pharma LTD Description and Business Overview
    • 11.1.3 Anuh Pharma LTD Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Anuh Pharma LTD Rosuvastatin (CAS 287714-41-4) Products Offered
    • 11.1.5 Anuh Pharma LTD Related Developments
  • 11.2 Anwita Drugs & Chemicals Pvt Ltd
    • 11.2.1 Anwita Drugs & Chemicals Pvt Ltd Corporation Information
    • 11.2.2 Anwita Drugs & Chemicals Pvt Ltd Description and Business Overview
    • 11.2.3 Anwita Drugs & Chemicals Pvt Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Anwita Drugs & Chemicals Pvt Ltd Rosuvastatin (CAS 287714-41-4) Products Offered
    • 11.2.5 Anwita Drugs & Chemicals Pvt Ltd Related Developments
  • 11.3 Aspen Biopharma Labs Pvt Ltd
    • 11.3.1 Aspen Biopharma Labs Pvt Ltd Corporation Information
    • 11.3.2 Aspen Biopharma Labs Pvt Ltd Description and Business Overview
    • 11.3.3 Aspen Biopharma Labs Pvt Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Aspen Biopharma Labs Pvt Ltd Rosuvastatin (CAS 287714-41-4) Products Offered
    • 11.3.5 Aspen Biopharma Labs Pvt Ltd Related Developments
  • 11.4 DSM Sinochem Pharmaceuticals
    • 11.4.1 DSM Sinochem Pharmaceuticals Corporation Information
    • 11.4.2 DSM Sinochem Pharmaceuticals Description and Business Overview
    • 11.4.3 DSM Sinochem Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 DSM Sinochem Pharmaceuticals Rosuvastatin (CAS 287714-41-4) Products Offered
    • 11.4.5 DSM Sinochem Pharmaceuticals Related Developments
  • 11.5 Jeil Pharmaceutical Co., Ltd
    • 11.5.1 Jeil Pharmaceutical Co., Ltd Corporation Information
    • 11.5.2 Jeil Pharmaceutical Co., Ltd Description and Business Overview
    • 11.5.3 Jeil Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Jeil Pharmaceutical Co., Ltd Rosuvastatin (CAS 287714-41-4) Products Offered
    • 11.5.5 Jeil Pharmaceutical Co., Ltd Related Developments
  • 11.6 Jubilant Life Sciences Limited
    • 11.6.1 Jubilant Life Sciences Limited Corporation Information
    • 11.6.2 Jubilant Life Sciences Limited Description and Business Overview
    • 11.6.3 Jubilant Life Sciences Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Jubilant Life Sciences Limited Rosuvastatin (CAS 287714-41-4) Products Offered
    • 11.6.5 Jubilant Life Sciences Limited Related Developments
  • 11.7 Kores India Limited
    • 11.7.1 Kores India Limited Corporation Information
    • 11.7.2 Kores India Limited Description and Business Overview
    • 11.7.3 Kores India Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Kores India Limited Rosuvastatin (CAS 287714-41-4) Products Offered
    • 11.7.5 Kores India Limited Related Developments
  • 11.8 Titan Laboratories Pvt Ltd
    • 11.8.1 Titan Laboratories Pvt Ltd Corporation Information
    • 11.8.2 Titan Laboratories Pvt Ltd Description and Business Overview
    • 11.8.3 Titan Laboratories Pvt Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Titan Laboratories Pvt Ltd Rosuvastatin (CAS 287714-41-4) Products Offered
    • 11.8.5 Titan Laboratories Pvt Ltd Related Developments
  • 11.1 Anuh Pharma LTD
    • 11.1.1 Anuh Pharma LTD Corporation Information
    • 11.1.2 Anuh Pharma LTD Description and Business Overview
    • 11.1.3 Anuh Pharma LTD Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Anuh Pharma LTD Rosuvastatin (CAS 287714-41-4) Products Offered
    • 11.1.5 Anuh Pharma LTD Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Rosuvastatin (CAS 287714-41-4) Market Estimates and Projections by Region
    • 12.1.1 Global Rosuvastatin (CAS 287714-41-4) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Rosuvastatin (CAS 287714-41-4) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Rosuvastatin (CAS 287714-41-4) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Rosuvastatin (CAS 287714-41-4) Sales Forecast (2021-2026)
    • 12.2.2 North America: Rosuvastatin (CAS 287714-41-4) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Rosuvastatin (CAS 287714-41-4) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Rosuvastatin (CAS 287714-41-4) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Rosuvastatin (CAS 287714-41-4) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Rosuvastatin (CAS 287714-41-4) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Rosuvastatin (CAS 287714-41-4) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Rosuvastatin (CAS 287714-41-4) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Rosuvastatin (CAS 287714-41-4) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Rosuvastatin (CAS 287714-41-4) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Rosuvastatin (CAS 287714-41-4) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Rosuvastatin (CAS 287714-41-4) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Rosuvastatin (CAS 287714-41-4) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Rosuvastatin (CAS 287714-41-4) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Rosuvastatin (CAS 287714-41-4) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Rosuvastatin (CAS 287714-41-4) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Rosuvastatin (CAS 287714-41-4) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Rosuvastatin (CAS 287714-41-4) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Rosuvastatin (CAS 287714-41-4) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Rosuvastatin (CAS 287714-41-4) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Rosuvastatin (CAS 287714-41-4) market is segmented 2, and 2. Players, stakeholders, and other participants in the global Rosuvastatin (CAS 287714-41-4) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast 2 and 2 for the period 2015-2026.

    Segment 2, the Rosuvastatin (CAS 287714-41-4) market is segmented into
    Purity ≥98%
    Purity ≥99%

    Segment 2, the Rosuvastatin (CAS 287714-41-4) market is segmented into
    5mg Tablet
    10mg Tablet
    20mg Tablet
    40mg Tablet

    Regional and Country-level Analysis
    The Rosuvastatin (CAS 287714-41-4) market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Rosuvastatin (CAS 287714-41-4) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Brazil, Turkey, GCC Countries, Egypt, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast 2, and 2 segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Rosuvastatin (CAS 287714-41-4) Market Share Analysis
    Rosuvastatin (CAS 287714-41-4) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rosuvastatin (CAS 287714-41-4) business, the date to enter into the Rosuvastatin (CAS 287714-41-4) market, Rosuvastatin (CAS 287714-41-4) product introduction, recent developments, etc.

    The major vendors covered:
    Anuh Pharma LTD
    Anwita Drugs & Chemicals Pvt Ltd
    Aspen Biopharma Labs Pvt Ltd
    DSM Sinochem Pharmaceuticals
    Jeil Pharmaceutical Co., Ltd
    Jubilant Life Sciences Limited
    Kores India Limited
    Titan Laboratories Pvt Ltd

    Buy now